2025
|
Invention
|
Biomarkers for nanoparticle compositions.
The present invention provides methods and composition... |
2024
|
Invention
|
Methods of treating central nervous system disorders via administration of nanoparticles of an mt... |
2023
|
Invention
|
Methods of treating hematological malignancy using nanoparticle mtor inhibitor combination therap... |
|
Invention
|
Nanoparticle comprising rapamycin and albumin as anticancer agent.
The present invention feature... |
|
Invention
|
Methods of treating colon cancer using nanoparticle mtor inhibitor combination therapy.
The pres... |
2022
|
Invention
|
Biomarkers for nanoparticle compositions.
The present application provides methods and compositi... |
|
Invention
|
Pharmaceutical compositions of albumin and rapamycin.
The present invention provides composition... |
|
Invention
|
Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly wate... |
|
Invention
|
Methods of treating solid tumors using nanoparticle mtor inhibitor combination therapy.
The pres... |
2021
|
Invention
|
Methods of treating epithelioid cell tumors. The present invention provides methods and compositi... |
2020
|
Invention
|
Methods and compositions for treating pulmonary hypertension.
The present invention features met... |
|
Invention
|
Methods and compositions for treating pulmonary hypertension.
The present applications provides ... |
|
Invention
|
Biomarkers for nanoparticle compositions. The present application provides methods and compositio... |
|
Invention
|
Pharmaceutical compositions of albumin and rapamycin. The present invention provides compositions... |
|
Invention
|
Intravascular delivery of nanoparticle compositions and uses thereof.
The present invention prov... |
|
Invention
|
Subcutaneous administration of nanoparticles comprising an mtor inhibitor and albumin for treatme... |
|
Invention
|
Combinations and modes of administration of therapeutic agents and combination therapy.
The pres... |
2019
|
Invention
|
Combination therapy comprising nanoparticles of a taxane and albumin with abt-263 in methods for ... |
|
Invention
|
Methods of treating bladder cancer.
The present invention provides methods and compositions for ... |
|
Invention
|
Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel.... |
|
Invention
|
Methods and compositions for treating pulmonary hypertension. The present applications provides m... |
|
Invention
|
Methods and compositions for treating pulmonary hypertension. e.ge.ge.ge.ge.ge.g., an albumin). |
|
Invention
|
Methods of treating cancer.
The present invention provides methods and compositions for treating... |
|
Invention
|
Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents.
The... |
2018
|
Invention
|
Methods of treating colon cancer using nanoparticle mtor inhibitor combination therapy. The prese... |
|
Invention
|
Nanoparticle compositions of albumin and paclitaxel.
The present invention provides compositions... |
|
Invention
|
Combination therapy methods for treating proliferative diseases.
The present invention provides ... |
2017
|
Invention
|
Nanoparticle formulations and methods of making and using thereof.
The present invention provide... |
|
Invention
|
Methods of treating biliary tract cancer.
The present invention provides methods and composition... |
|
Invention
|
Methods of treating mitochondrial and metabolic disorders.
The present invention relates to meth... |
|
Invention
|
Methods for assessing neoadjuvant therapies.
Therapies compared in clinical studies can he asses... |
|
P/S
|
Injectable pharmaceutical for the treatment of cancer. |
2016
|
P/S
|
Pharmaceuticals for the treatment of cancer. |
2011
|
P/S
|
Pharmaceutical preparations for the treatment of cancer. |
2010
|
P/S
|
Pharmaceutical for the treatment of cancer.
Injectable pharmaceutical for the treatment of cancer. |
2006
|
P/S
|
Pharmaceuticals, namely, oncolytics; pharmaceuticals for the treatment of cancer; [ pharmaceutica... |
|
P/S
|
medical and pharmaceutical information services [; medical and pharmaceutical consultation servic... |
|
P/S
|
Pharmaceuticals, namely, oncolytics; pharmaceuticals for the treatment of cancer; pharmaceuticals... |
2005
|
P/S
|
Pharmaceuticals for the treatment of cancer. Research and development in the field of pharmaceuti... |
|
P/S
|
Medical information services in connection with cancer, cancer treatment and new advances in canc... |
2004
|
P/S
|
Pharmaceutical for the treatment of cancer. |
|
P/S
|
Pharmaceutical for the treatment of cancer. |
|
P/S
|
Pharmaceutical for the treatment of cancer |
2003
|
P/S
|
Pharmaceuticals for the treatment of cancer research and development in the field of pharmaceutic... |
|
P/S
|
Injectable pharmaceutical for the treatment of cancer |
1995
|
P/S
|
Proprietary medicine for prostate treatment. |